CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.29
-0.59 (-0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
62.49
+1.20 (1.96%)
After-hours: Mar 9, 2026, 7:34 PM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.18 billion as of March 9, 2026. Its market cap has increased by 140.88% in one year.
Market Cap
5.18B
Enterprise Value
4.44B
1-Year Change
140.88%
Ranking
Category
Stock Price
$61.29
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.18B, an increase of 329.05%. That is a compound annual growth rate of 99.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.22B | 56.00% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 5.88B |
| Immunovant | 5.43B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |
| PTC Therapeutics | 5.20B |